SHINEWAY PHARM(02877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02877 SHINEWAY PHARM

Early Closed 12-31 12:08:29

8.600

+0.070

+0.82%

High8.630	Low8.520	Vol616.27K
Open8.530	D1 Closing8.530	Amplitude1.29%
Mkt Cap7.11B	Tradable Cap7.11B	Total Shares827.00M
T/O5.29M	T/O Rate0.07%	Tradable Shares827.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02877","market":"HK","secType":"STK","nameCN":"SHINEWAY PHARM","latestPrice":8.6,"timestamp":1767154109006,"preClose":8.53,"halted":0,"volume":616268,"delay":0,"floatShares":827000000,"shares":827000000,"eps":1.2395386047851062,"marketStatus":"Early Closed","change":0.07,"latestTime":"12-31 12:08:29","open":8.53,"high":8.63,"low":8.52,"amount":5285731,"amplitude":0.012896,"askPrice":8.6,"askSize":96000,"bidPrice":8.59,"bidSize":31000,"shortable":3,"etf":0,"ttmEps":1.2172459879204869,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767317400000},"marketStatusCode":6,"adr":0,"listingDate":1101916800000,"exchange":"SEHK","adjPreClose":8.53,"dividendRate":0.058744,"openAndCloseTimeList":[[1767144600000,1767153600000]],"volumeRatio":1.036091,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02877/wiki","defaultTab":"wiki","newsList":[{"id":"2593440711","title":"Benign Growth For China Shineway Pharmaceutical Group Limited (HKG:2877) Underpins Its Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2593440711","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593440711?lang=en_us&edition=fundamental","pubTime":"2025-12-24 06:35","pubTimestamp":1766529357,"startTime":"0","endTime":"0","summary":"When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") above 13x, you may consider...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/benign-growth-for-china-shineway-pharmaceutical-group-limite","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/benign-growth-for-china-shineway-pharmaceutical-group-limite","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"1189334100","title":"Guoyuan International Initiates \"Buy\" Rating on SHINEWAY PHARM with Target Price of HK$10.04","url":"https://stock-news.laohu8.com/highlight/detail?id=1189334100","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189334100?lang=en_us&edition=fundamental","pubTime":"2025-12-18 17:30","pubTimestamp":1766050237,"startTime":"0","endTime":"0","summary":"Guoyuan International released a research report stating that SHINEWAY PHARM (02877) has made smooth progress in innovative traditional Chinese medicine (TCM) R&D. Its core product, Sailuotong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"1195150442","title":"HK Stock Movement | SHINEWAY PHARM (02877) Falls Over 2% in Afternoon Trading as Q3 Revenue Drops 16.3% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1195150442","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195150442?lang=en_us&edition=fundamental","pubTime":"2025-11-07 13:40","pubTimestamp":1762494012,"startTime":"0","endTime":"0","summary":"SHINEWAY PHARM (02877) declined over 2% in afternoon trading, dropping 2.14% to HKD 8.69 by the time of writing, with a turnover of HKD 5.3445 million. The company announced during the midday break...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","02877","BK1191"],"gpt_icon":0},{"id":"1142444254","title":"China Shineway Pharmaceutical (2877) Announces RMB 2,415 Million Turnover for First Nine Months of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1142444254","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142444254?lang=en_us&edition=fundamental","pubTime":"2025-11-07 12:23","pubTimestamp":1762489390,"startTime":"0","endTime":"0","summary":"China Shineway Pharmaceutical Group Limited (2877) recorded a turnover of RMB 2,415 million for the nine months ended 30 September 2025, reflecting a 16.3% decrease compared with the same period in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02877"],"gpt_icon":0},{"id":"2581907024","title":"China Shineway Pharmaceutical Group Reports 16.3% Drop in Nine-Month Turnover","url":"https://stock-news.laohu8.com/highlight/detail?id=2581907024","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581907024?lang=en_us&edition=fundamental","pubTime":"2025-11-07 12:07","pubTimestamp":1762488425,"startTime":"0","endTime":"0","summary":"China Shineway Pharmaceutical Group Limited announced that its turnover for the nine months ended 30 September 2025 was RMB 2,415 million, representing a decrease of 16.3% compared to the same period in 2024. Turnover of injection products declined by 23.6% to RMB 786 million, soft capsule products decreased by 13.7% to RMB 337 million, granule products fell by 14.5% to RMB 391 million, TCM formula granule products dropped by 11.8% to RMB 726 million, and products in other forms decreased by 6.1% to RMB 175 million. Injection products, soft capsule products, granule products, and TCM formula granule products accounted for approximately 32.5%, 14.0%, 16.2%, and 30.1% of total turnover, respectively, during the period. The results are based on management accounts that have not been reviewed by auditors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDLbKGkyK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","02877","BK1191"],"gpt_icon":0},{"id":"2581600024","title":"China Shineway Pharmaceutical - Nine Months Turnover RMB 2,415 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581600024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581600024?lang=en_us&edition=fundamental","pubTime":"2025-11-07 12:02","pubTimestamp":1762488129,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WI33T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02877","BK1606"],"gpt_icon":0},{"id":"2581073307","title":"China Shineway Pharmaceutical Group's (HKG:2877) three-year earnings growth trails the 28% YoY shareholder returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2581073307","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581073307?lang=en_us&edition=fundamental","pubTime":"2025-11-07 07:08","pubTimestamp":1762470532,"startTime":"0","endTime":"0","summary":"By buying an index fund, investors can approximate the average market return. But if you choose individual stocks with...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/china-shineway-pharmaceutical-groups-hkg2877-three-year-earn-1","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/china-shineway-pharmaceutical-groups-hkg2877-three-year-earn-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02877"],"gpt_icon":0},{"id":"1165551350","title":"CHINA SHINEWAY PHARMACEUTICAL (02877) Announces Monthly Equity Movements Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1165551350","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165551350?lang=en_us&edition=fundamental","pubTime":"2025-10-31 19:07","pubTimestamp":1761908844,"startTime":"0","endTime":"0","summary":"CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED (02877) reported no changes to its authorized share capital or issued shares as of October 31, 2025. The company's authorized share capital remained at HKD...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02877"],"gpt_icon":0},{"id":"1167140309","title":"Stock Track | China Shineway Pharmaceutical Soars 5.39% on Strong H1 Results and Dividend Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1167140309","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167140309?lang=en_us&edition=fundamental","pubTime":"2025-08-27 13:17","pubTimestamp":1756271861,"startTime":"0","endTime":"0","summary":"China Shineway Pharmaceutical Group (02877.HK) saw its stock price surge 5.39% in intraday trading on Wednesday, following the release of impressive first-half financial results and the declaration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02877"],"gpt_icon":0},{"id":"2562379986","title":"China Shineway Pharmaceutical Posts Lower H1 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2562379986","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562379986?lang=en_us&edition=fundamental","pubTime":"2025-08-27 12:52","pubTimestamp":1756270353,"startTime":"0","endTime":"0","summary":"China Shineway Pharmaceutical Group  reported 614.7 million yuan in attributable profit for the first half of 2025, down 2% from 626.5 million yuan a year earlier, according to a Hong Kong bourse filing Wednesday.Earnings per share were 0.81 yuan, compared with 0.83 yuan in the prior year.Revenue decreased 21% year-on-year to 1.65 billion yuan, figures showed.The pharmaceutical company declared a dividend of HK$0.12 per share, payable Sept. 26 to shareholders of record on Sept. 12.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1606","02877","BK1191"],"gpt_icon":0},{"id":"1114042671","title":"SHINEWAY PHARM (02877) Reports Interim Results with Net Profit of 615 Million Yuan, Down 1.89% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1114042671","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114042671?lang=en_us&edition=fundamental","pubTime":"2025-08-27 12:08","pubTimestamp":1756267723,"startTime":"0","endTime":"0","summary":"SHINEWAY PHARM (02877) announced its interim results for 2025, reporting revenue of 1.653 billion yuan (RMB), representing a 20.8% decrease compared to the same period last year. Net profit for the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02877","BK1606"],"gpt_icon":0},{"id":"2562938795","title":"China Shineway Pharmaceutical Group H1 Gross Margin 72.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562938795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562938795?lang=en_us&edition=fundamental","pubTime":"2025-08-27 12:00","pubTimestamp":1756267237,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nPLX7855CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1606","02877"],"gpt_icon":0},{"id":"2562795930","title":"China Shineway Pharmaceutical -  Declared 2025 Second Interim Dividend of RMB11 Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2562795930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562795930?lang=en_us&edition=fundamental","pubTime":"2025-08-27 12:00","pubTimestamp":1756267237,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nPLX7855CC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","02877","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shineway.com.hk","stockEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0274},{"period":"3month","weight":0.0191},{"period":"6month","weight":0.0406},{"period":"1year","weight":-0.0635},{"period":"ytd","weight":-0.0566}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0002},{"period":"3month","weight":-0.0373},{"period":"6month","weight":0.0741},{"period":"1year","weight":0.2901},{"period":"ytd","weight":0.2889}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.027599},{"month":2,"riseRate":0.571429,"avgChangeRate":0.035482},{"month":3,"riseRate":0.619048,"avgChangeRate":0.018687},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048381},{"month":5,"riseRate":0.52381,"avgChangeRate":0.036559},{"month":6,"riseRate":0.380952,"avgChangeRate":-0.02111},{"month":7,"riseRate":0.190476,"avgChangeRate":-0.060268},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.001388},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.000678},{"month":10,"riseRate":0.666667,"avgChangeRate":0.016588},{"month":11,"riseRate":0.52381,"avgChangeRate":0.056933},{"month":12,"riseRate":0.47619,"avgChangeRate":-0.00305}],"exchange":"SEHK","name":"SHINEWAY PHARM","nameEN":"SHINEWAY PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SHINEWAY PHARM(02877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SHINEWAY PHARM(02877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SHINEWAY PHARM,02877,SHINEWAY PHARM股票,SHINEWAY PHARM股票老虎,SHINEWAY PHARM股票老虎国际,SHINEWAY PHARM行情,SHINEWAY PHARM股票行情,SHINEWAY PHARM股价,SHINEWAY PHARM股市,SHINEWAY PHARM股票价格,SHINEWAY PHARM股票交易,SHINEWAY PHARM股票购买,SHINEWAY PHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SHINEWAY PHARM(02877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SHINEWAY PHARM(02877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}